Navigation Links
Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration
Date:3/7/2012

MOUNTAIN VIEW, Calif., March 7, 2012 /PRNewswire/ -- Today, Cobalt Technologies, a leading developer of next generation n-butanol, announced the achievement of major progress toward commercial scale by successfully demonstrating its biomass pretreatment process. Cobalt in cooperation with ANDRITZ, a globally leading supplier of technologies, equipment and plants for the pulp and paper industry, tested its dilute acid hydrolysis pretreatment process, the first step of Cobalt's process for converting sugars into n-butanol for use as a renewable chemical or fuel.

"Demonstrating our high-yield pretreatment process is a key milestone for Cobalt as we prove that our n-butanol technology will efficiently work at commercial scale and at an attractive low cost," said Bob Mayer, CEO of Cobalt Technologies. "This is a very exciting time at Cobalt as we continue our path to commercialization and deepen our relationships with key partners."

Cobalt conducted the testing in the ANDRITZ pulp and paper mill demonstration facility in Springfield, OH, which is specifically designed to validate new processes before commercial-scale implementation. Cobalt's dilute acid hydrolysis pretreatment process, which extracts sugars from ligno-cellulosic biomass, was validated on woody biomass, bagasse and agricultural residues.

"We have extensive experience and expertise in process know-how and technologies for biomass processing and were eager to work with Cobalt on this project," said Bertil Stromberg, vice president of biofuel for ANDRITZ.

Using ANDRITZ's proven pulp processing equipment, Cobalt tested its pre-treatment process on both a batch and continuous basis, proving both its flexibility and efficiency for potential customers. These runs, while processing up to 20 bone-dry tons of biomass per day, successfully extracted sugars from the biomass without the use of enzymes t
'/>"/>

SOURCE Cobalt Technologies
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014 Throughout this ... across the clinical trials space, representing 38 countries ... series entitled “Optimizing Patient Participation in Clinical Trials. ... off with internationally renowned R&D expert, Ken Getz, ... on Reinventing Drug Development through Patient Centricity. , ...
(Date:7/14/2014)... Mass. , July 14, 2014 Minerva ... the development of new therapies to treat neuropsychiatric diseases ... has been appointed vice president of finance and ... Mr. Ahlholm is a senior executive with more than ... at technology and life science companies. His background includes ...
(Date:7/14/2014)... Mateo, CA (PRWEB) July 14, 2014 ... CONNECT patient registry platform, announced that three ... muscular dystrophies; the Phelan-McDermid Syndrome International Registry; ... Nephrotic Syndrome—have been awarded contracts by the ... of the creation of a new health ...
(Date:7/13/2014)... R.I. (Brown University) -- The discovery 30 years ago ... an explosion of nanotechnology research. Now, there appears to ... from Brown University, Shanxi University and Tsinghua University in ... atoms forms a hollow molecular cage similar to a ... boron cage structurepreviously only a matter of speculationdoes indeed ...
Breaking Biology Technology:Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 3
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) today announced ... scheduled to present at the Rodman & Renshaw,10th Annual ... Tuesday, November 11th, 2008 at 2:50 p.m. Eastern Time ... 2008 at the,Palace Hotel in New York., The ...
... Driven by the emergence of innovative technologies ... and proteomics, world market for drug discovery ... by 2012. Despite the heavy costs involved ... pharmaceutical research and development are reaching new ...
... of Wisconsin-Madison engineers and physicists have developed a method ... that could lay the foundation for faster flexible electronics. ... electronic devices. Silicon thin films could be the basis ... inducing strain into the silicon increases device speed, yet ...
Cached Biology Technology:Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts 2Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts 3Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts 4Stretching silicon: A new method to measure how strain affects semiconductors 2
(Date:7/14/2014)... of Kansas scientists to the discovery and description of ... collections specimen, which turned out to represent a new genus ... ripidiine wedge beetle from Borneo is discussed in a recent ... . , The holotype male, and only known specimen ... in Borneo but subsequent to this it was transferred among ...
(Date:7/14/2014)... environment manage much better in the struggle for survival ... A world without bees would be a whole lot ... million to 1 billion Danish kroner are earned annually ... and pollinating a wide range of crops from apples ... the world are under pressure from pesticides, mites, viruses, ...
(Date:7/14/2014)... The Roquin protein, discovered in 2005, controls T-cell ... certain mRNAs. In doing so, it helps to ... the body,s own structures that can lead to ... Autoimmune diseases affect between five and ten per ... a result of complex environmental influences when a ...
Breaking Biology News(10 mins):Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 3Best for bees to be stay-at-homes 2Molecular mechanisms underlying the prevention of autoim-munity by Roquin revealed 2
... Since the 1960s, psychiatrists have been hunting for substances ... high levels to produce the symptoms associated with schizophrenia. ... might be related to the hallucinogens phencyclidine (PCP) or ... of psychotic symptoms in schizophrenia. This "auto-intoxication" hypothesis led ...
... March 14, 2013 In the largest ever ... genetics company, identified 20 new genetic associations for myopia, ... in the study, which was specific to individuals of ... data and survey responses from more than 50,000 23andMe ...
... to feed, some whales throw their jaws wide and engulf ... along with their mouths agape (ram or skim feeding), yet ... whales, mouths to filter nutrition from the ocean: baleen. Alexander ... how the hairy substance actually traps morsels of food. ,The ...
Cached Biology News:The mysterious GRIN3A and the cause of schizophrenia 223andMe identifies multiple genetic factors impacting development of nearsightedness 2Whale's streaming baleen tangles to trap food 2
... Serum; U.S. sourced, ideal for ... quality; Low hemoglobin; Endotoxin: < ... of US origin; U.S. sourced, ... an uncompromising quality. Low hemoglobin ...
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
Fetal Calf Serum Replacement (Bistec) serum...
...
Biology Products: